About the Authors
- Jatinder K. Juss
-
Affiliations Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke’s and Papworth Hospitals, Cambridge, United Kingdom, Inositide Laboratory, The Babraham Institute, Cambridge, United Kingdom
- Richard P. Hayhoe
-
Affiliation Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke’s and Papworth Hospitals, Cambridge, United Kingdom
- Charles E. Owen
-
Affiliation Novartis, Horsham Research Centre, Horsham, United Kingdom
- Ian Bruce
-
Affiliation Novartis, Horsham Research Centre, Horsham, United Kingdom
- Sarah R. Walmsley
-
Affiliation Academic Unit of Respiratory Medicine, The Medical School, University of Sheffield, Sheffield, United Kingdom
- Andrew S. Cowburn
-
Affiliation Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke’s and Papworth Hospitals, Cambridge, United Kingdom
- Suhasini Kulkarni
-
Affiliation Inositide Laboratory, The Babraham Institute, Cambridge, United Kingdom
- Keith B. Boyle
-
Affiliation Inositide Laboratory, The Babraham Institute, Cambridge, United Kingdom
- Len Stephens
-
Contributed equally to this work with: Len Stephens, Phillip T. Hawkins, Edwin R. Chilvers, Alison M. Condliffe
Affiliation Inositide Laboratory, The Babraham Institute, Cambridge, United Kingdom
- Phillip T. Hawkins
-
Contributed equally to this work with: Len Stephens, Phillip T. Hawkins, Edwin R. Chilvers, Alison M. Condliffe
Affiliation Inositide Laboratory, The Babraham Institute, Cambridge, United Kingdom
- Edwin R. Chilvers
-
Contributed equally to this work with: Len Stephens, Phillip T. Hawkins, Edwin R. Chilvers, Alison M. Condliffe
Affiliation Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke’s and Papworth Hospitals, Cambridge, United Kingdom
- Alison M. Condliffe
-
Contributed equally to this work with: Len Stephens, Phillip T. Hawkins, Edwin R. Chilvers, Alison M. Condliffe
* E-mail: amc46@medschl.cam.ac.uk
Affiliation Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke’s and Papworth Hospitals, Cambridge, United Kingdom
Competing Interests
Ian Bruce and Charles Owen are employed by Novartis. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: ERC AMC PTH CEO LS SK KB. Performed the experiments: JKJ RPH. Analyzed the data: JKJ RPH. Contributed reagents/materials/analysis tools: ISB. Wrote the paper: AMC ERC PTH LS. Developed novel experimental methodologies: SRW ASC.